Last reviewed · How we verify

NCT03912922: SITLESS4

SIT LESS 4: How Does Reducing Sitting Time Improve Glucose and Lipid Metabolism?

Completed NA Last updated 20 January 2021
What this trial tests

NA trial testing Activity regime in Overweight and Obesity in 12 participants. Completed in 13 March 2020.

Timeline
15 December 2017
Primary endpoint
13 March 2020
13 March 2020

Quick facts

Lead sponsorMaastricht University Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeprevention
Enrollment12
Start date15 December 2017
Primary completion13 March 2020
Estimated completion13 March 2020
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Maastricht University Medical Center

Who can join

Adults 45 to 70, female only, with Overweight and Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Research has shown that replacing sitting time with low intensity physical activity (such as slowly walking and standing) has beneficial effects on metabolic health, like insulin sensitivity, comparable to improvements after sitting all day in combination with 1h streneous exercise. The main objective of this study is to investigate the underlying mechanisms responsible for improved insulin sensitivity after 4 days of sitting less compared to sitting and exercise in healthy obese women. Our secondary objective is to investigate the effects of sitting less on cardio metabolic parameters.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Sitting less elicits metabolic responses similar to exercise and enhances insulin sensitivity in postmenopausal women.
    Remie CME, Janssens GE, Bilet L, van Weeghel M, et al · · 2021 · cited 20× · PMID 34510226 · DOI 10.1007/s00125-021-05558-5

Verify or expand the search:

Other recruiting trials for Overweight and Obesity

Currently open trials in the same condition.

Other Maastricht University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03912922.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing